Publication No. of sexual partners (Mean(SD)) or proportion of multiple sexual partners (%) Drug use or needle sharing
(% or Mean(SD))
Alcoholabuse *
(% or Mean(SD))
IG CG IG CG IG CG
Kelly et al. [32] N/A N/A Drug use
I1: 70.4→55.6 PM3,F3
I2: 64.3→64.3 PM3,F3
Drug use
63.0→63.0 PM3,F3
I1: 88.9→88.9 PM3,F3
I2: 92.9→78.6 PM3,F3
85.2→85.2 PM3,F3
Kalichman et al. [37] APPM3
1.6(2.4)→1.3(2.3)PM3,F3
1.6(2.4)→1.2(1.9)PM3,F6
APPM3
1.7(3.3)→1.2(1.5)PM3,F3
1.7(3.3)→1.3(1.9)PM3,F6
N/A N/A N/A N/A
Margolin et al. [23] N/A N/A Needle sharing
44.4→12.9 PM1,F0
44.4→11.8 PM1,F3
Needle sharing
53.3→22.6 PM1,F0
53.3→10.7 PM1,F3
N/A N/A
Sorensen et al.[38] N/A N/A Drug use
0.2(0.13)→0.2(0.14)PM1,F6
0.2(0.13)→0.2(0.13)PM1,F12
0.2(0.13)→0.1(0.10)PM1,F18
Needle sharing
1.2(0.99)→0.6(0.84) PM1,F6
1.2(0.99) → 0.7(0.90) PM1,F12
1.2(0.99) → 0.3(0.65) PM1,F18
Drug use
0.2(0.13)→0.2(0.13)PM1,F6
0.2(0.13)→0.1(0.12)PM1,F12
0.2(0.13)→0.1(0.10)PM1,F18
Needle sharing
1.2(1.06)→0.7(0.98) PM1,F6
1.2(1.06)→0.8(1.04) PM1,F12
1.2(1.06)→0.5(0.89) M1,F18
0.2(0.25→0.2(0.22) PM1,F6
0.2(0.25→0.1(0.18) PM1,F12
0.2(0.25→0.1(0.16)PM1,F18
0.2(0.26→0.2(0.22) PM1,F6
0.2(0.26→0.2(0.23) PM1,F12
0.2(0.26→0.1(0.19) PM1,F18
Purcell et al. [39] N/A N/A Needle sharing for HNUP 28.6→9.7 PM3,F3
28.6→7.3 PM3,F6
28.6→5.8 PM3,F12
Needle sharing for HNUP
28.9→12.0 PM3,F3
28.9→10.6 PM3,F6
28.9→6.6 PM3,F12
N/A N/A
Gilbert et al. [24] CPPM3
-2.3(9.2)F3
-2.7(8.4)F6
CPPM3
-1.4(7.9)F3
-0.6(5.6)F6
Drug use
43.8→38.5PM3,F3
43.8→29.5PM3,F6
Drug use
41.1→41.5PM3,F3
41.1→42.5PM3,F6
Any risk drinking2
38.3→26.4 PM3,F3
38.3→23.5 PM3,F6
Any risk drinking2
39.0→29.8PM3,F3
39.0→27.5PM3,F6
Williams et al. [40] APPM6
6.69(1.43)→3.46(0.51)F0
6.69(1.43)→2.34(0.47)
F36.69(1.43)→1.69(0.19)F6
APPM6
5.49(1.32)→3.49(0.47)F05.
49(1.32)→3.12(0.43)F35.
49(1.32)→1.71(0.17)F6
N/A N/A N/A N/A
Coleman et al. [41] APPM3
81.8→45.0F3
APPM3
78.6→53.9F3
N/A N/A N/A N/A
Rose et al. [8] APPM6
5.2(16.3)→ 4.3(9.9)F6
HNUPPM6
3.1(3.8)→ 1.5(2.0)F6
APPM6
4.6(16.0)→ 8.1(67.3)F6
HNUPPM6
2.3(2.3)→0.8(1.2)F6
N/A N/A N/A N/A
Teti et al. [22] APPM6
2.50(4.36)→4.57(16.66)F6
2.50(4.36)→1.50(0.81)F12
2.50(4.36)→1.40(0.84)F18
APPM6
2.24(3.52)→5.15(15.91)F6
2.24(3.52)→2.77(4.39)F12
2.24(3.52)→1.40(1.30)F18
N/A N/A N/A N/A
Wolitski et al. [9] APPM3
27.2→22.6F6
27.2→20.6F12
27.2→24.3F18
APPM3
29.2→20.9F6
29.2→21.1F12
29.2→21.1F18
N/A N/A N/A N/A
Kalichman et al. [20] HNUPPM3
0.6(1.8)→0.5(1.4)F3
0.6(1.8)→0.6(1.1)F6
0.6(1.8)→0.04(0.6)F9
HNUPPM3
0.7(3.1)→0.6(1.3)F3
0.7(3.1)→0.9(5.1)F6
0.7(3.1)→0.4(0.6)F9
N/A N/A N/A N/A
Note: IG: intervention group; CG: control groups; SD: standard deviation; AP: any partners; HNUP: HIV-negative or unknown partners; IDU: injection drug use; DU: drug users; I1: cognitive-behavioral group intervention; I2: social support group intervention; N/A: not available;
*Alcohol abuse was defined as exceeding the US National Institute on Alcoholism and Alcohol Abuse’s recommended numbers of drinks per week (14 or fewer for men; 7 or fewer for women) and or 3 or more binge drinking pisodes (5 or more drinks on 1 occasion for men; 4 or more drinks on 1 occasion for women).
PM1: In the past month; PM3: In the past 3 months; PM6: In the past 6 months;
F0: Immediately after intervention; F3: At 3-month follow-up; F6: At 6-month follow-up; F9: At 9-month follow-up; F12: At12-month follow-up; F18: At 18-month follow-up.
Table 3: Efficacy of risk reductioninterventions on number of sexual partners and drug and alcohol abuse among persons living with HIV/AIDS.
Goto home»